Overview

Midodrine in the Recovery Phase of Septic Shock

Status:
Terminated

Trial end date:
2018-05-02

Target enrollment:

Participant gender:

Summary

The aim of this study is to investigate the role of oral midodrine in the recovery of septic shock. The investigators hypothesize that the oral drug can reduce central line days and ICU length of stay.

Phase:

Phase 3

Details

Lead Sponsor:

University of Virginia

Treatments:

Midodrine